CIBC Asset Management
NMTR

CIBC Asset Management’s 9 Meters Biopharma NMTR Stock Holding History

CIBC Asset Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,722
Closed -$22K – 1124
2023
Q2 		$22K Hold
32,722
– – ﹤0.01% 1092
2023
Q1 		$45.5K Buy
+32,722
New +$61.7K ﹤0.01% 1032

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

CIBC Asset Management's NMTR Position: Q3 2023 in Review

CIBC Asset Management sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 32,722 shares — an estimated $22K sold.

CIBC Asset Management first reported a position in NMTR in Q1 2023 and held it in 2 quarters. The position peaked at $45.5K in Q1 2023. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • CIBC Asset Management reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • CIBC Asset Management sold 32,722 9 Meters Biopharma shares in Q3 2023, an estimated $22K.
  • CIBC Asset Management first reported a position in 9 Meters Biopharma in Q1 2023 and held it in 2 quarters.
  • CIBC Asset Management's 9 Meters Biopharma position peaked at $45.5K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on CIBC Asset Management's 13F filing for Q3 2023, filed 30 Oct 2023.